Laurus Labs Limited

LAURUSLABS.BO·BSE·Healthcare
Compare
2,345.00+38.90 (+1.69%)today
At close: Nov 5, 3:28 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2,306.10
Open2,334.65
Day range2,288.652,345.00
52-week range913.352,442.00
Off day high0.00%
Off 52-week high−3.97%
Volume59.73K
Avg. volume (3M)93.01K
Market cap1.27T
EPS (TTM)24.78
Forward P/E66.21
P/E ratio (TTM)94.63
Dividend yield0.09% (2.00)
Beta (5Y)0.22
Shares outstanding540.31M
Short interest—
Earnings dateOct 29, 2026 (est.)
Analyst target2,156.29
Profit margin17.13%

Against its peers

Compare in full ›
LAURUSLABS.BO AUROPHARMA.BO LUPIN.NS DRREDDY.BO ALKEM.BO IPCALAB.NS
Market cap 1.27T 1.04T 909.09B 1.13T 620.96B 494.62B
P/E (TTM) 94.6 30.4 17.5 20.1 28.7 37.8
Forward P/E 66.2 23.9 19.6 24.8 23.2 27.7
Price/book 20.9 3.0 3.8 3.0 4.5 6.1
Dividend yield 0.09% 0.33% 0.90% 0.65% 0.39% 0.30%
1-year change +135.57% +1.70% +2.72% +0.33% −8.21% +51.13%
Today +1.69% +5.13% −1.03% −0.82% +0.07% −1.14%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Related companies

Compare ›

Other companies in Drug Manufacturers - Specialty & Generic, closest in size first.

Company Mkt cap Price Today
Daewoong Pharmaceutical Co., Ltd069620.KS · Seoul, South Korea 1.23T 106,700.00 +3.69%
Zydus Lifesciences LimitedZYDUSLIFE.BO · Ahmedabad, India 1.19T 1,196.40 +0.54%
PT Pyridam Farma TbkPYFA.JK · Jakarta Selatan, Indonesia 1.21T 108.00 −4.42%
Kyowa Kirin Co., Ltd.4151.T · Chiyoda, Japan 1.37T 2,620.50 +6.07%
Dr. Reddy's Laboratories LimitedDRREDDY.BO · Hyderabad, India 1.13T 1,360.80 −0.82%
Eisai Co., Ltd.4523.T · Tokyo, Japan 1.49T 5,280.00 +6.09%
Cipla LimitedCIPLA.BO · Mumbai, India 1.13T 1,401.75 +0.12%
PT Merck TbkMERK.JK · Jakarta Timur, Indonesia 1.58T 3,530.00 +2.92%

The stocks whose daily moves over the past year went most closely with Laurus Labs's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Zydus Lifesciences LimitedZYDUSLIFE.NS · Correlation 0.48 1.19T 1,193.00 +0.41%
Divi's Laboratories LimitedDIVISLAB.BO · Correlation 0.46 2.69T 10,150.00 +1.14%
Mankind Pharma LimitedMANKIND.NS · Correlation 0.43 1.04T 2,518.00 −0.78%
Granules India LimitedGRANULES.NS · Correlation 0.41 216.71B 794.45 −0.02%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP.BO · Correlation 0.39 1.20T 8,359.05 −2.54%
Sai Life Sciences LimitedSAILIFE.NS · Correlation 0.38 338.79B 1,594.50 +3.13%
Neuland Laboratories LimitedNEULANDLAB.BO · Correlation 0.38 253.67B 19,771.85 +0.80%
Lupin LimitedLUPIN.NS · Correlation 0.37 909.09B 1,988.00 −1.03%

What visitors to Laurus Labs's page also look at.

Company Mkt cap Price Today
GRANULES INDIA LTD.GRANULES.BO 192.80B 794.50 −0.01%
DIVIS LABORATORIES LTD.DIVISLAB.BO 2.69T 10,150.00 +1.14%
AUROBINDO PHARMA LTD.AUROPHARMA.BO 1.04T 1,788.30 +5.13%
Syngene International LimitedSYNGENE.BO 167.62B 417.05 −0.04%
NATCO PHARMA LTD.NATCOPHARM.BO 144.14B 804.75 +1.92%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All LAURUSLABS.BO news ›
InvestyWise·Positive

Laurus Labs reports 29% revenue growth in Q2 FY27

Laurus Labs announced strong Q2 FY27 results with total revenues of INR2,206 crores, a 29% YoY increase. CDMO and affordable medicines segments drove growth, with healthy margins and strategic investments in peptides and oligonucleotides.…

PRLB
TradingView·Positive

Laurus Labs Ltd.

LAURUSLABS Stock Price and Chart — NSE:LAURUSLABS TradingView Compare with Laurus Labs Ltd. Q2 FY26 saw 35% revenue growth, margin expansion, and robust ARV and CDMO performance. Major CapEx and new Vizag facility support long-term growth,…

TSLA
BusinessLine·Positive

Laurus Labs’ Q2 Results: Net more than doubles at ₹441 cr

Laurus Labs’ net profit more than doubled at ₹441 crore in the second quarter of the current financial year ended September compared to ₹195 crore in the corresponding quarter of the previous financial year. The total revenue of the…

The Hindu·Positive

Laurus Labs Q2 net profit surges on 33% rise in revenue

Updated - October 29, 2026 08:56 pm IST - HYDERABAD Pharmaceutical and biotechnology company Laurus Labs reported a more than twofold increase in consolidated net profit to ₹436.74 crore for the September quarter, driven by a 33% growth in…

From the 4Search news index, newest first.

In the news

24mentions in 30 days
24with it in the headline
Positivesentiment

Mentioned with

Krish Capital Pty Ltd13Laurus Labs Limited9Aurobindo Pharma7Biochem Group6Galenvs Sciences6Kura Oncology6Krka Pharma Private Limited5Mankind Pharma5

People in the coverage

G. Venkateswar Reddy11Ganesh Chandra Patro11Akrapoint6Blueshift4Gaurav K. Gupta4Jeffrey Leitzell4

Themes

SEC Filings11India10Announcements8Healthcare8Indian Stock Market7Pharmaceuticals7Healthcarebiotech6Kura6

Most coverage from

  1. thehindubusinessline.com4
  2. freepressjournal.in3
  3. moneycontrol.com3
  4. businessupturn.com2
  5. medicaldialogues.in2

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 24 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance